[
  {
    "ts": null,
    "headline": "Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2024 Update",
    "summary": "Read here for an update on Prem Watsa's latest 13F portfolio changes, including new stakes in Kraft-Heinz and notable increases in Under Armour and Micron.",
    "url": "https://finnhub.io/api/news?id=b90ef73bce79f940a3c60ec5e4d3ae5f21ab0ac9189e46e9e6f6a30f705d0eba",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732233477,
      "headline": "Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2024 Update",
      "id": 131554281,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1264256639/image_1264256639.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Read here for an update on Prem Watsa's latest 13F portfolio changes, including new stakes in Kraft-Heinz and notable increases in Under Armour and Micron.",
      "url": "https://finnhub.io/api/news?id=b90ef73bce79f940a3c60ec5e4d3ae5f21ab0ac9189e46e9e6f6a30f705d0eba"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks",
    "summary": "Analyzing Pfizer's stock potential: Undervalued with a high dividend yield, strong Q3 results, DCF analysis showing potential undervaluation.",
    "url": "https://finnhub.io/api/news?id=1aa3291f57bb0d0c0cc453e7c4187e48120da3986192f744a087397eb4ead9d4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732212258,
      "headline": "Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks",
      "id": 131549390,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1299632091/image_1299632091.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Analyzing Pfizer's stock potential: Undervalued with a high dividend yield, strong Q3 results, DCF analysis showing potential undervaluation.",
      "url": "https://finnhub.io/api/news?id=1aa3291f57bb0d0c0cc453e7c4187e48120da3986192f744a087397eb4ead9d4"
    }
  },
  {
    "ts": null,
    "headline": "PFE vs. NVO: Which Stock Is the Better Value Option?",
    "summary": "PFE vs. NVO: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=3b7df6409f6e67cf56a8e59f61d05cf6dceca0693f8f9de09356e4b3e4709995",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732207209,
      "headline": "PFE vs. NVO: Which Stock Is the Better Value Option?",
      "id": 131546209,
      "image": "https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PFE vs. NVO: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=3b7df6409f6e67cf56a8e59f61d05cf6dceca0693f8f9de09356e4b3e4709995"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Pfizer Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=5be208feb433e64805aa0e23f343bbf708725e2d32d9f790febc385375881fe4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732207200,
      "headline": "Pfizer Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 131601001,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=5be208feb433e64805aa0e23f343bbf708725e2d32d9f790febc385375881fe4"
    }
  },
  {
    "ts": null,
    "headline": "Major companies that are also popular short-selling stocks",
    "summary": "Investor confidence in certain major companies has propelled markets higher, but there are also those betting against big-name stocks through short selling.",
    "url": "https://finnhub.io/api/news?id=ef36cbb6e5effbbb2e069c2e202455f6dbbe3c74945907ed9c6eafc2be38c1a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732203797,
      "headline": "Major companies that are also popular short-selling stocks",
      "id": 131540283,
      "image": "https://s.yimg.com/ny/api/res/1.2/CYH1yU6WbI6qd4kjrYG4mw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2024-11/9d1b3b60-a812-11ef-9faf-1f4090cbc5b5",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investor confidence in certain major companies has propelled markets higher, but there are also those betting against big-name stocks through short selling.",
      "url": "https://finnhub.io/api/news?id=ef36cbb6e5effbbb2e069c2e202455f6dbbe3c74945907ed9c6eafc2be38c1a0"
    }
  },
  {
    "ts": null,
    "headline": "Allocating $50K In A Dividend Portfolio: Enhancing SCHD With 10 High-Yield Picks",
    "summary": "Learn how to build a $50k dividend portfolio by enhancing Schwab U.S. Dividend Equity ETF with November's top 10 high dividend yield picks. Click for more on SCHD.",
    "url": "https://finnhub.io/api/news?id=6d8998b00220ef3bfa30c498ca0dd75b039af0a1a45dd39f9af21f1e19e8c2ce",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732201200,
      "headline": "Allocating $50K In A Dividend Portfolio: Enhancing SCHD With 10 High-Yield Picks",
      "id": 131543990,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1226730172/image_1226730172.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Learn how to build a $50k dividend portfolio by enhancing Schwab U.S. Dividend Equity ETF with November's top 10 high dividend yield picks. Click for more on SCHD.",
      "url": "https://finnhub.io/api/news?id=6d8998b00220ef3bfa30c498ca0dd75b039af0a1a45dd39f9af21f1e19e8c2ce"
    }
  },
  {
    "ts": null,
    "headline": "5 Best Value Stocks With Discounted PEG to Boost Your Portfolio Return",
    "summary": "Here are the five PEG-driven value stocks that fit our screening criteria - INGR, PFE, LDOS, LTM and BABA.",
    "url": "https://finnhub.io/api/news?id=5fe682143236cb5b582b163a9d4ec8799f11fd5ca03b3a883a25afd417a9f337",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732200600,
      "headline": "5 Best Value Stocks With Discounted PEG to Boost Your Portfolio Return",
      "id": 131542247,
      "image": "https://media.zenfs.com/en/zacks.com/08d295f8913d1d597be87f944e8a8f5c",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Here are the five PEG-driven value stocks that fit our screening criteria - INGR, PFE, LDOS, LTM and BABA.",
      "url": "https://finnhub.io/api/news?id=5fe682143236cb5b582b163a9d4ec8799f11fd5ca03b3a883a25afd417a9f337"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair",
    "summary": "Adobe, Pfizer, Dollar General, Snap and Ryanair are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=ac7a958b0d142beb7e9374e4be2c04ce4629259193a998557fdd458038f878e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732197840,
      "headline": "The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair",
      "id": 131540396,
      "image": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Adobe, Pfizer, Dollar General, Snap and Ryanair are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=ac7a958b0d142beb7e9374e4be2c04ce4629259193a998557fdd458038f878e9"
    }
  },
  {
    "ts": null,
    "headline": "Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS?",
    "summary": "Is Pfizer stock a sell after shares skidded on the news Trump selected Kennedy to take over HHS? Is PFE stock now a sell?",
    "url": "https://finnhub.io/api/news?id=3de6e19fc8ebe9d38b741b7ee6ba02e8f139e7dc1159708b6b51662fa2064eef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732195819,
      "headline": "Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS?",
      "id": 131546221,
      "image": "",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Is Pfizer stock a sell after shares skidded on the news Trump selected Kennedy to take over HHS? Is PFE stock now a sell?",
      "url": "https://finnhub.io/api/news?id=3de6e19fc8ebe9d38b741b7ee6ba02e8f139e7dc1159708b6b51662fa2064eef"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU",
    "summary": "Following approval from the European Commission, PFE's Hympavzi becomes the first hemophilia medicine in the European Union to be administered via a pre-filled, auto-injector pen.",
    "url": "https://finnhub.io/api/news?id=28c2a86deb42a4c1a9fc34a614410689461bb4effaf5661c2242ddfe62ec59ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732195440,
      "headline": "Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU",
      "id": 131540195,
      "image": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Following approval from the European Commission, PFE's Hympavzi becomes the first hemophilia medicine in the European Union to be administered via a pre-filled, auto-injector pen.",
      "url": "https://finnhub.io/api/news?id=28c2a86deb42a4c1a9fc34a614410689461bb4effaf5661c2242ddfe62ec59ab"
    }
  },
  {
    "ts": null,
    "headline": "2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist",
    "summary": "For those looking for great candidates, here are two in the healthcare sector: Merck (NYSE: MRK) and Pfizer (NYSE: PFE).  Is Merck's Keytruda empire crumbling?  The company's famous cancer drug is by far its biggest growth driver and typically accounts for over 40% of its revenue.",
    "url": "https://finnhub.io/api/news?id=ee3ea85adc57beebe465db6251c530c42311a11ec69af5933bab03ce22e5aef8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732194900,
      "headline": "2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist",
      "id": 131546227,
      "image": "https://g.foolcdn.com/editorial/images/798009/doctor-and-patient-talking.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "For those looking for great candidates, here are two in the healthcare sector: Merck (NYSE: MRK) and Pfizer (NYSE: PFE).  Is Merck's Keytruda empire crumbling?  The company's famous cancer drug is by far its biggest growth driver and typically accounts for over 40% of its revenue.",
      "url": "https://finnhub.io/api/news?id=ee3ea85adc57beebe465db6251c530c42311a11ec69af5933bab03ce22e5aef8"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Announces New Chief Scientific Officer and President, Research and Development",
    "summary": "NEW YORK - Pfizer Inc. today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and...",
    "url": "https://finnhub.io/api/news?id=b79733ba296ee8cc76b223d88f0edacb4c2672469f4dde0f08a505f7d16acc08",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732182735,
      "headline": "Pfizer Announces New Chief Scientific Officer and President, Research and Development",
      "id": 131539084,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "NEW YORK - Pfizer Inc. today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and...",
      "url": "https://finnhub.io/api/news?id=b79733ba296ee8cc76b223d88f0edacb4c2672469f4dde0f08a505f7d16acc08"
    }
  },
  {
    "ts": null,
    "headline": "EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia",
    "summary": "The authorisation extends to all 27 EU member states, along with Liechtenstein, Iceland and Norway.",
    "url": "https://finnhub.io/api/news?id=15297603e411657b5825ba54b876579b97eeb18c6896212bb47e74b497888554",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732181445,
      "headline": "EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia",
      "id": 131535116,
      "image": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/11/Pharma-1-Pfizerr-Shutterstock_2415297481.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The authorisation extends to all 27 EU member states, along with Liechtenstein, Iceland and Norway.",
      "url": "https://finnhub.io/api/news?id=15297603e411657b5825ba54b876579b97eeb18c6896212bb47e74b497888554"
    }
  },
  {
    "ts": null,
    "headline": "2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years",
    "summary": "High-yielding stocks can be due for cuts to their payouts if a company's underlying financials aren't strong enough to support its dividend payments.  Two good examples of stocks that pay more than 6% and can still be ideal long-term options for retirees are Pfizer (NYSE: PFE) and Verizon Communications (NYSE: VZ).  A bearish outlook for the future has resulted in Pfizer's stock price tumbling more than 10% this year, despite what has generally been a strong year for the markets.",
    "url": "https://finnhub.io/api/news?id=5b86135fae69beeceef4a7af37ac2c72ea98f49f7bb8b173e80d477dcb2cd2ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732181100,
      "headline": "2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years",
      "id": 131533531,
      "image": "https://g.foolcdn.com/editorial/images/798053/a-person-working-on-their-computer.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "High-yielding stocks can be due for cuts to their payouts if a company's underlying financials aren't strong enough to support its dividend payments.  Two good examples of stocks that pay more than 6% and can still be ideal long-term options for retirees are Pfizer (NYSE: PFE) and Verizon Communications (NYSE: VZ).  A bearish outlook for the future has resulted in Pfizer's stock price tumbling more than 10% this year, despite what has generally been a strong year for the markets.",
      "url": "https://finnhub.io/api/news?id=5b86135fae69beeceef4a7af37ac2c72ea98f49f7bb8b173e80d477dcb2cd2ab"
    }
  },
  {
    "ts": null,
    "headline": "Tribunal fines drug firms £69m for excessive pricing after CMA investigation",
    "summary": "Firms which raised prices for key epilepsy medicine - causing NHS costs to soar to £50 million - found by the CAT to have breached competition law.* In a judgment handed down today, the CAT found...",
    "url": "https://finnhub.io/api/news?id=65362c79756beb232d1c67787cd728ecfd43543da7b3187a0f83facde227bb8f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732162568,
      "headline": "Tribunal fines drug firms £69m for excessive pricing after CMA investigation",
      "id": 131531076,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Firms which raised prices for key epilepsy medicine - causing NHS costs to soar to £50 million - found by the CAT to have breached competition law.* In a judgment handed down today, the CAT found...",
      "url": "https://finnhub.io/api/news?id=65362c79756beb232d1c67787cd728ecfd43543da7b3187a0f83facde227bb8f"
    }
  }
]